Switch in Differentiative Response to Maturation Inducers of Human Promyelocytic Leukemia Cells by Prior Exposure to Alkaline Conditions

Cancer Research

Volumn 45, Issue 5, 1985, Pages 2065-2069

  Fischkoff, Steven A ^a   Condon, Margaret E ^a  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID;

BLOOD AND HEMOPOIETIC SYSTEM; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HL 60; DIFFERENTIATION; EOSINOPHIL; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; PH; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THERAPY;

BUTYRIC ACID; BUTYRIC ACIDS; CELL DIFFERENTIATION; CELLS, CULTURED; DIMETHYL SULFOXIDE; EOSINOPHILS; HUMAN; HYDROGEN-ION CONCENTRATION; LEUKEMIA, MYELOCYTIC, ACUTE; NEUTROPHILS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; TRETINOIN;

EID: 0021857579     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bodner, A. J., Tmg, R.C., and Gallo. R. C. Induction of differentiation of human prornyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J. Natl. Cancer Inst. 67:1025–1030.1981.
2. Boyd. A. W. and Metcalf, D. Induction of differentiation in HL60 leukaemic cells: a cell cycle dependent all-or-none event. Leuk. Res. 8:27–43.1984.
3. Breitman. T. R. Selonick. S. E. and Coins. S. J. Induction of dfflerentiation of the human prornyelocytic leukemia cell line (HL-60) by retinoic add. Proc. Natl. Acad. Sei. USA. 77:2936–2940.1980.
4. Chapinski, T. J., and Niedel. J. E. Cyclic nucleotidennduced maturation of human prornyelocytic leukemia eels. J. Clin. Invest. 70:953–964.1982.
5. Chen. Z.-X., Banks. J. Rifkind, R. A., and Marks. P. A. Inducer-mediated commitment of murine erythroteukemia eels to dfferentiation: a multstep process. Proc. Natl. Acad. Sci. USA. 79:471–475.1982.
6. Coins. S. J. Ruscetti. F. W. Galagher, R. E. and Galo. R. C. Terminal dfferentiation of human prornyelocytic leukemia eels induced by clmethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sei. USA. 75:2458–2462.1978.
7. Coins. S. J., Bodner. A. Ting. R. and Galo. R. C. Induction of rrwrphological and functional dffierentiation of human prornyelocytic leukemia eels (HL-60) by compounds which induce differentiation of murine leukemia eels. Int. J. Cancer, 25:213–218.1980.
8. Ferrero, D., Tarela, C, Galo, E., Ruscetti. F. W., and Breitman, T. R. Terminal differentiation of the human prornyelocytic leukemia cell Ine, HL-60, in the absence of eel proliferation. Cancer Res., 42:4421–4426,1982.
9. Fischkoff, S. A., Polak, A. Gleich. G. J. Testa, J. R. Misawa. S. and Reber. T. J. Eosinophic differentiation of the human promyelocytic leukemia cell Ine, HL-60. J. Exp. Med. 160:179–196.1984.
10. Fischkoff. S. A. Papuchis. G. C., and Nickde. W. A. Decreased activity of acetyt-Co A carboxylase during chemically induced neutrophilic differentiation of human prornyelocytic leukemia cells. J. Cell. Biochem. 26:75–81.1984.
11. Fontana, J. A. Cotoert. D. A., and Deisseroth. A. B. Identification of a population of bipotent stem eels in the HL60 human prornyelocytic leukemia cell Ine. Proc. Natl. Acad. Sei. USA, 78:3863–3866,1981.
12. Koeffler, H. P., and Golde, D. W. Human myeloid leukemia eel Ines: a review. Blood, 56:344–350.1980.
13. Li, C. Y. Lam, K. W., and Yam, L T. Esterases in human leukocytes. J. Histochem. Cytochem., 21:1–12,1973.
14. McCarthy, D. M., San Miguel, J. F., Freake. H. C., Green, P. M., Zola, H. Catovsky, D., and Goldman, J. M. 1,25-DilliyoYoxyvitamin D, inhibits proifera-tion of human prornyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow eels. Leuk. Res., 7:51–55,1983.
15. Metcalf, D. Clonal analysis of the response of HL60 human myeloid leukemia cells to biological regulators. Leuk. Res. 7:117–132.1983.
16. Nakayasu. M., Terada. M. Tamura, G., and Sugimura, T. Induction of drffer-entiation of humanan abd mirine myeloid leukemia cells in culture by tunicmycin. Proc. Natl. Acad. Sei. USA. 77:409–413.1980.
17. Rovera, G., and Surrey, S. Use of resistant or hypersensitive variant clones of Friend eels in analysis of mode of action of inducers. Cancer Res., 38:3737–3744,1978.
18. Rovera, G., Santoll, D., and Damsky, C. Human prornyelocytic leukemia cells in culture differentiate into rrtacrophage-tke cells when treated with a phorbol diester. Proc. Natl. Acad. Sci. USA, 76:2779–2783,1979.